Data availability
Not applicable.
References
Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP et al (2022) Diagnosis and treatment of orthostatic hypotension. Lancet Neurol 21(8):735–746. https://doi.org/10.1016/s1474-4422(22)00169-7
Palma JA, Kaufmann H (2017) Epidemiology, diagnosis, and management of neurogenic orthostatic hypotension. Mov Disord Clin Pract 4(3):298–308. https://doi.org/10.1002/mdc3.12478
De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT (2017) Association of autonomic dysfunction with disease progression and survival in parkinson disease. JAMA Neurol 74(8):970–976. https://doi.org/10.1001/jamaneurol.2017.1125
Rascol O, Perez-Lloret S, Damier P, Delval A, Derkinderen P, Destée A et al (2015) Falls in ambulatory non-demented patients with Parkinson’s disease. J Neural Transm (Vienna) 122(10):1447–1455. https://doi.org/10.1007/s00702-015-1396-2
Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K et al (2015) Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord 30(5):639–645. https://doi.org/10.1002/mds.26079
Arbogast SD, Alshekhlee A, Hussain Z, McNeeley K, Chelimsky TC (2009) Hypotension unawareness in profound orthostatic hypotension. Am J Med 122(6):574–580. https://doi.org/10.1016/j.amjmed.2008.10.040
Freeman R, Illigens BMW, Lapusca R, Campagnolo M, Abuzinadah AR, Bonyhay I et al (2020) Symptom recognition is impaired in patients with orthostatic hypotension. Hypertension 75(5):1325–1332. https://doi.org/10.1161/hypertensionaha.119.13619
Tipton PW, Cheshire WP (2020) Mechanisms underlying unawareness of neurogenic orthostatic hypotension. Clin Auton Res 3:279–281
Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S et al (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 264(8):1567–1582. https://doi.org/10.1007/s00415-016-8375-x
Ruiz Barrio I, Miki Y, Jaunmuktane ZT, Warner T, De Pablo-Fernandez E (2023) Association between orthostatic hypotension and dementia in patients with Parkinson disease and multiple system atrophy. Neurology 100(10):e998–e1008. https://doi.org/10.1212/wnl.0000000000201659
Longardner K, Bayram E, Litvan I (2020) Orthostatic hypotension is associated with cognitive decline in Parkinson disease. Front Neurol 11:897. https://doi.org/10.3389/fneur.2020.00897
Xia X, Wang R, Vetrano DL, Grande G, Laukka EJ, Ding M et al (2021) From normal cognition to cognitive impairment and dementia: impact of orthostatic hypotension. Hypertension 78(3):769–778. https://doi.org/10.1161/hypertensionaha.121.17454
McDonald C, Newton JL, Burn DJ (2016) Orthostatic hypotension and cognitive impairment in Parkinson’s disease: causation or association? Mov Disord 31(7):937–946. https://doi.org/10.1002/mds.26632
Donnell DO, Romero-Ortuno R, Kennelly SP, O’Neill D, Donoghue PO, Lavan A et al (2023) The ‘Bermuda Triangle’ of orthostatic hypotension, cognitive impairment and reduced mobility: prospective associations with falls and fractures in the Irish longitudinal study on ageing. Age Ageing 52(2):afad005. https://doi.org/10.1093/ageing/afad005
Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S et al (2018) Autonomic dysfunction in Parkinson’s disease: a prospective cohort study. Mov Disord 33(3):391–397. https://doi.org/10.1002/mds.27268
Hauser RA, Heritier S, Rowse GJ, Hewitt LA, Isaacson SH (2016) Droxidopa and reduced falls in a trial of parkinson disease patients with neurogenic orthostatic hypotension. Clin Neuropharmacol 39(5):220–226. https://doi.org/10.1097/wnf.0000000000000168
Sharabi Y, Goldstein DS (2011) Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease. J Neurol Sci 310(1–2):123–128. https://doi.org/10.1016/j.jns.2011.06.047
Jordan J, Fanciulli A, Tank J, Calandra-Buonaura G, Cheshire WP, Cortelli P et al (2019) Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. J Hypertens 37(8):1541–1546. https://doi.org/10.1097/hjh.0000000000002078
Fanciulli A, Göbel G, Ndayisaba JP, Granata R, Duerr S, Strano S et al (2016) Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res 26(2):97–105. https://doi.org/10.1007/s10286-015-0336-4
Palma JA, Redel-Traub G, Porciuncula A, Samaniego-Toro D, Millar Vernetti P, Lui YW et al (2020) The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension. Parkinsonism Relat Disord 75:97–104. https://doi.org/10.1016/j.parkreldis.2020.04.011
Lim TS, Lee PH, Kim HS, Yong SW (2009) White matter hyperintensities in patients with multiple system atrophy. J Neurol 256(10):1663–1670. https://doi.org/10.1007/s00415-009-5176-5
Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331. https://doi.org/10.1212/WNL.0b013e31826c1acd
Pilleri M, Facchini S, Gasparoli E, Biundo R, Bernardi L, Marchetti M et al (2013) Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol 260(1):253–259. https://doi.org/10.1007/s00415-012-6627-y
Newman L, O’Connor JD, Romero-Ortuno R, Reilly RB, Kenny RA (2021) Supine hypertension is associated with an impaired cerebral oxygenation response to orthostasis: finding from the Irish longitudinal study on ageing. Hypertension 78(1):210–219. https://doi.org/10.1161/hypertensionaha.121.17111
Earle W, Kondo J, Kendrick KN, Turkson-Ocran RA, Ngo L, Cluett JL et al (2023) Association of supine hypertension versus standing hypotension with adverse events among middle-aged adults. Hypertension 80(11):2437-2446. https://doi.org/10.1161/hypertensionaha.123.21215
de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen J (2019) Blood pressure variability and progression of clinical alzheimer disease. Hypertension 74(5):1172–1180. https://doi.org/10.1161/hypertensionaha.119.13664
Alves M, Caldeira D, Ferreira JJ (2023) Blood pressure variability in Parkinson’s disease patients—case control study. Clin Park Relat Disord 8:100191. https://doi.org/10.1016/j.prdoa.2023.100191
Niehaus L, Böckeler GC, Kupsch A, Meyer BU (2002) Normal cerebral hemodynamic response to orthostasis in Parkinson’s disease. Parkinsonism Relat Disord 8(4):255–259. https://doi.org/10.1016/s1353-8020(01)00014-1
Angeli S, Marchese R, Abbruzzese G, Gandolfo C, Conti M, Gasparetto B et al (2003) Tilt-table test during transcranial Doppler monitoring in Parkinson’s disease. Parkinsonism Relat Disord 10(1):41–46. https://doi.org/10.1016/s1353-8020(03)00069-5
Gurevich T, Gur AY, Bornstein NM, Giladi N, Korczyn AD (2006) Cerebral vasomotor reactivity in Parkinson’s disease, multiple system atrophy and pure autonomic failure. J Neurol Sci 243(1–2):57–60. https://doi.org/10.1016/j.jns.2005.11.028
Pavy-Le Traon A, Hughson RL, Thalamas C, Galitsky M, Fabre N, Rascol O et al (2006) Cerebral autoregulation is preserved in multiple system atrophy: a transcranial Doppler study. Mov Disord 21(12):2122–2126. https://doi.org/10.1002/mds.21130
Novak V, Novak P, Spies JM, Low PA (1998) Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke 29(1):104–111. https://doi.org/10.1161/01.str.29.1.104
Indelicato E, Fanciulli A, Poewe W, Antonini A, Pontieri FE, Wenning GK (2015) Cerebral autoregulation and white matter lesions in Parkinson’s disease and multiple system atrophy. Parkinsonism Relat Disord 21(12):1393–1397. https://doi.org/10.1016/j.parkreldis.2015.10.018
Xing Y, Li Q, Xu E, Zeng J, Mei S, Hua Y (2022) Impaired cerebral autoregulation in parkinson’s disease: an orthostatic hypotension analysis. Front Neurol 13:811698. https://doi.org/10.3389/fneur.2022.811698
Harms MP, Colier WN, Wieling W, Lenders JW, Secher NH, van Lieshout JJ (2000) Orthostatic tolerance, cerebral oxygenation, and blood velocity in humans with sympathetic failure. Stroke 31(7):1608–1614. https://doi.org/10.1161/01.str.31.7.1608
Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL et al (1995) Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 70(7):617–622. https://doi.org/10.4065/70.7.617
Funding
There was no targeted funding for the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Guillaume Lamotte received honoraria for his role as managing editor of the journal Clinical Autonomic Research.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lenka, A., Lamotte, G. & Beach, P. Asymptomatic orthostatic hypotension in synucleinopathies: to treat or not to treat?. Clin Auton Res 34, 25–29 (2024). https://doi.org/10.1007/s10286-023-01006-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-023-01006-z